Cantor Fitzgerald Maintains Overweight on CVRx, Lowers Price Target to $5
CVRx (CVRX) Q2 2026 Earnings Call Transcript
CVRx, Inc. (CVRX) Presents at Canaccord Genuity's 46th Annual Growth Conference - Slideshow
CVRx Announces Sales Leadership Transition
Lake Street Downgrades CVRx to Hold, Lowers Price Target to $3.5
CVRx, Inc. Q2 2026 Earnings Call Summary
CVRx, Inc. (CVRX) Q2 2026 Earnings Call Transcript
CVRx Inc (CVRX) (Q2 2026) Earnings Call Highlights: Sales Execution Challenges Offset Strong ...
CVRx (CVRX) Reports Q2 Loss, Beats Revenue Estimates
CVRx Q2 Earnings Call Highlights
Compared to Estimates, CVRx (CVRX) Q2 Earnings: A Look at Key Metrics
CVRx Lowers FY2026 Sales Guidance from $63.000M-$67.000M to $58.000M-$60.000M vs $65.340M Est
CVRx Sees Q3 Sales $13.500M-$14.500M vs $16.840M Est
CVRx to Present at Canaccord Genuity's 46th Annual Growth Conference
CVRx to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call on August 6, 2026
CVRx, Inc. (CVRX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
CVRx Announces Chief Financial Officer Transition
CVRx CFO Jared Oasheim Stepping Down
CVRx, Inc. (CVRX) Presents at 46th Annual William Blair Growth Stock Conference - Slideshow
CVRx to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.